Antifungal Efficacy during Candida krusei Infection in Non-Conventional Models Correlates with the Yeast In Vitro Susceptibility Profile
Figure 5
Efficacy of fluconazole during G. mellonella infection with C. krusei or C. albicans.
Effect of fluconazole during infection of larvae with 5×106 cells of C. krusei (ATCC 6258) per larvae (A and B) and 5×105 cells of C. albicans cells (SC5314) per larva (C and D) in G. mellonella. Fluconazole treatment with 4 or 12 mg/kg (A and C); 32, 64 or 128 mg/kg (B and D).